Eloxx Pharmaceuticals, Inc. SEC filings ELOX

Eloxx Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Dec 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 17, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K Annual report Mar 6, 2020 Dec 31, 2019
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 19, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2018 Dec 31, 2017
10-K Annual report Oct 13, 2017 Jun 30, 2017
10-K/A Amended annual report Nov 16, 2016 Jun 30, 2016
10-K/A Amended annual report Oct 28, 2016 Jun 30, 2016
10-K Annual report Oct 13, 2016 Jun 30, 2016
10-K/A Amended annual report Oct 28, 2015 Jun 30, 2015
10-K Annual report Oct 9, 2015 Jun 30, 2015
ARS Annual report to shareholders Nov 4, 2014 Jun 30, 2014
10-K Annual report Sep 29, 2014 Jun 30, 2014
ARS Annual report to shareholders Jan 8, 2014 Jun 30, 2013
10-K/A Amended annual report Sep 25, 2013 Jun 30, 2013
10-K Annual report Sep 11, 2013 Jun 30, 2013
ARS Annual report to shareholders Mar 1, 2013 Jun 30, 2012
10-K/A Amended annual report Oct 26, 2012 Jun 30, 2012
10-K Annual report Sep 28, 2012 Jun 30, 2012
ARS Annual report to shareholders Nov 9, 2011 Jun 30, 2011
10-K/A Amended annual report Oct 24, 2011 Jun 30, 2011
10-K Annual report Sep 28, 2011 Jun 30, 2011
ARS Annual report to shareholders Feb 14, 2011 Jun 30, 2010
10-K/A Amended annual report Oct 25, 2010 Jun 30, 2010
10-K Annual report Sep 28, 2010 Jun 30, 2010
ARS Annual report to shareholders Apr 30, 2010 Jun 30, 2009
10-K/A Amended annual report Oct 28, 2009 Jun 30, 2009
10-K Annual report Sep 28, 2009 Jun 30, 2009

Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ELOX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1035354
Former names
Sevion Therapeutics, Inc. (until Dec 22, 2017); SENESCO TECHNOLOGIES INC (until Sep 29, 2014); NAVA LEISURE USA INC (until May 24, 1999)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.